Redhill Biopharma Ltd-sp Adr Share Price (NASDAQ: RDHL)

Redhill Biopharma Ltd-sp Adr Stock Performance

as on October 14, 2025 at 1:29 am IST

Day's Low
Day's High
$1.59
Day's Price Range
$1.74
$1.63
2.45%
Downside
6.75%
Upside
52 Week's Low
52 Week's High
$1.06
52-Week Price Range
$9
$1.63
34.97%
Downside
452.15%
Upside

Redhill Biopharma Ltd-sp Adr share price movements today

Previous Close: $1.70
Open: $1.70
Volume: 582.9K
Day's Low - High: $1.59 - $1.74
52 Week Low - High: $1.06 - $9

Redhill Biopharma Ltd-sp Adr Historical Returns

1 Month Return: + 7.95 %
3 Month Return: -25.23 %
1 Year Return: -79.57 %
3 Year Return: -99.69 %
5 Year Return: -99.98 %

Redhill Biopharma Ltd-sp Adr Stock Fundamentals & Key Indicators

Check Redhill Biopharma Ltd-sp Adr market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.7M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-8.3M

Revenue (TTM)

9.6M

Profit Margin

-97.52%

Return On Equity TTM

-1708.61%

Redhill Biopharma Ltd-sp Adr vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Redhill Biopharma Ltd-sp Adr with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Redhill Biopharma Ltd-sp Adr	BUY	$5.7M	-99.98%	NA	-97.52%
United Therapeutics Corporation	BUY	$19.9B	NA	17.16	40.36%
Haleon Plc Spon Ads	BUY	$40.6B	NA	20	13.81%
Neurocrine Biosciences Inc.	BUY	$13.6B	35.95%	40.64	13.88%
Zoetis Inc.	BUY	$63.0B	-13.08%	24.53	27.83%

Stock Returns calculator for Redhill Biopharma Ltd-sp Adr Stock including INR - Dollar returns

The Redhill Biopharma Ltd-sp Adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Redhill Biopharma Ltd-sp Adr investment value today

Current value as on today

₹26,194

Returns

₹73,806

(-73.81%)

Returns from Redhill Biopharma Ltd-sp Adr Stock

₹79,574 (-79.57%)

Dollar Returns*

₹5,768 (+5.77%)

Analyst Recommendation on Redhill Biopharma Ltd-sp Adr Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Redhill Biopharma Ltd-sp Adr. Average target price of $19000

Redhill Biopharma Ltd-sp Adr Share Price Target

Get share price movements and forecasts by analysts on Redhill Biopharma Ltd-sp Adr.

What analysts predicted

99.99%UPSIDE

Target Price

$19000

Current Price

$1.63

Analyzed by

7 Analysts

Target

$19000.00

Redhill Biopharma Ltd-sp Adr target price $19000, a slight upside of 99.99% compared to current price of $1.63. According to 7 analysts rating.

Redhill Biopharma Ltd-sp Adr Stock’s Investor Sentiment and Interest

Search interest for Redhill Biopharma Ltd-sp Adr Stock has increased by 49% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 14, 2025 to October 14, 2025

Change:49% versus previous 30 day period

Redhill Biopharma Ltd-sp Adr Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025
Total Revenue	17	12	12	1	0	1	1	2	2	2
Gross Profit	8	4	4	0	0	0	0	1	1	1
Operating Income	-7	-9	-9	-4	-6	-4	-4	-3	-2	-2
EBITDA	-1	0	0	2	-5	-4	-4	-1	-2	-2
Interest Expense	31	1	1	1	-	-	-	-	-	-
Depreciation	2	2	60	-58	-	-	-	-	-	-
Income Before Tax	-35	-3	-3	0	-13	-1	-1	-2	-2	-2
Income Tax Expense	28	-6	-6	0	-	-	-	-	-	-
Net Income	-35	2	-3	0	-13	-1	-1	-2	-2	-2
Net Profit Margin	-203.40%	19.46%	-29.14%	42.37%	-2386.43%	-120.06%	-120.06%	-94.68%	-101.32%	-101.32%

Redhill Biopharma Ltd-sp Adr Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	4	8	6	64	85	61	6	8
Gross Profit	-21	-30	1	5	4	27	36	28	3	4
Operating Income	-22	-30	-51	-39	-43	-63	-81	-42	12	-14
EBITDA	-21	-30	-45	-38	-40	-54	-63	-22	26	-7
Interest Expense	0	0	0	0	0	12	16	41	0	0
Depreciation	-	-	0	0	1	8	18	8	1	0
Income Before Tax	-21	-29	-45	-38	-42	-76	-97	-71	23	-8
Income Tax Expense	0	1	6	0	1	12	16	-12	0	-
Net Income	-21	-29	-45	-38	-42	-76	-97	-71	23	-8
Net Profit Margin	-703000.00%	-29079.21%	-1136.61%	-464.35%	-672.45%	-118.36%	-113.98%	-115.97%	366.25%	-102.80%

Redhill Biopharma Ltd-sp Adr Quarterly Cash Flow

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025
Net Income	-3	0	-13	-13	-1	-1	-2	-2	-2
Operating Cash Flow	-2	-10	-9	-	-3	-3	-1	-2	-2
Investing Cash Flow	-8	0	0	-	0	0	0	0	0
Financing Cash Flow	7	0	8	-	3	3	0	1	1
Change in Cash	4	-10	-6	-	-	7	-7	-	-

Redhill Biopharma Ltd-sp Adr Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-29	-45	-38	-42	-76	-97	-71	23	-8
Operating Cash Flow	-28	-44	-34	-40	-48	-65	-29	-35	-9
Investing Cash Flow	24	-18	5	5	-35	-8	8	0	0
Financing Cash Flow	36	25	41	35	84	73	11	21	8
Change in Cash	32	-37	12	0	0	0	-9	-14	0

Global Institutional Holdings in Redhill Biopharma Ltd-sp Adr

Funds	Holdings
UBS Group AG	0.34%
Federation des caisses Desjardins du Quebec	0.15%
GAMMA Investing LLC	0.09%
SBI Securities Co Ltd	0.09%
Morgan Stanley - Brokerage Accounts	0.08%

See all

Insights on Redhill Biopharma Ltd-sp Adr

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -2.59M → -2.06M (in $), with an average increase of 12.7% per quarter
NO EFFECT
Against Peers
In the last 3 years, United Therapeutics Corporation has given 103.3% return, outperforming this stock by 203.0%
NO EFFECT
Against Peers
In the last 1 year, United Therapeutics Corporation has given 23.2% return, outperforming this stock by 102.8%
NEGATIVE IMPACT
Price Dip
In the last 7 days, RDHL stock has moved down by -13.3%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 2.73M → 2.03M (in $), with an average decrease of 12.7% per quarter

About Redhill Biopharma Ltd-sp Adr

redhill biopharma is a biopharmaceutical company focused primarily on development of late clinical-stage new, improved and patented formulations of existing drugs. redhill has an experienced management team, board of directors and advisory board based in israel, the us, canada and europe, with successful track record at big and small pharma of bringing patented drugs to the market, as well as extensive managerial, financial, and transactional expertise

Organisation	Redhill Biopharma Ltd-sp Adr
Headquarters	21 Ha?arba?a Street, Tel Aviv, Israel, 6473921
Industry	Health Technology
CEO	Mr. Dror Ben-Asher
E-voting on shares	Click here to vote

Key Management of Redhill Biopharma Ltd-sp Adr

Name	Title
Mr. Rick D. Scruggs	Chief Commercial Officer & Director
Mr. Gilead Raday MPhil, MSc	Chief Operating Officer
Ms. Alexandra Okmian	Senior Business Development & Investor Relations Manager
Mr. Guy Goldberg J.D.	Chief Business Officer
Mr. Razi Ingber	Chief Financial Officer
Mr. Adi Frish	Chief Corporate & Business Development Officer
Dr. Mark L. Levitt M.D., Ph.D.	Chief Scientific Officer
Dr. Reza Fathi Ph.D.	Senior Vice President of Research & Development
Ms. Patricia Anderson B.Sc. RAC	Senior Vice President of Regulatory Affairs
Mr. Dror Ben-Asher	Co-Founder, Chairman & CEO

FAQs

What is Redhill Biopharma Ltd-sp Adr share price today?

Redhill Biopharma Ltd-sp Adr share price today is $1.63 as on October 14, 2025 at 1:29 am IST at the close of the market. Redhill Biopharma Ltd-sp Adr share today touched a day high of $1.74 and a low of $1.59.

What is the 52 week high and 52 week low for Redhill Biopharma Ltd-sp Adr share?

Redhill Biopharma Ltd-sp Adr share touched a 52 week high of $9 on October 21, 2024 and a 52 week low of $1.06 on August 8, 2025. Redhill Biopharma Ltd-sp Adr stock price today i.e. October 14, 2025 at 1:29 am IST is closed at $1.63,which is 81.89% down from its 52 week high and 53.77% up from its 52 week low.

What is Redhill Biopharma Ltd-sp Adr's market capitalisation today?

Redhill Biopharma Ltd-sp Adr market capitalisation is $0.00T as on October 14, 2025 at 1:29 am IST.

How to invest in Redhill Biopharma Ltd-sp Adr Stock (RDHL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Redhill Biopharma Ltd-sp Adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Redhill Biopharma Ltd-sp Adr Shares that will get you 0.9202 shares as per Redhill Biopharma Ltd-sp Adr share price of $1.63 per share as on October 14, 2025 at 1:29 am IST.

What is the minimum amount required to buy Redhill Biopharma Ltd-sp Adr Stock (RDHL) from India?

Indian investors can start investing in Redhill Biopharma Ltd-sp Adr (RDHL) shares with as little as ₹88.771 or $1 (as of October 14, 2025 at 5:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹887.71 in Redhill Biopharma Ltd-sp Adr stock (as per the Rupee-Dollar exchange rate as on October 14, 2025 at 5:40 pm IST). Based on Redhill Biopharma Ltd-sp Adr share’s latest price of $1.63 as on October 14, 2025 at 1:29 am IST, you will get 6.1350 shares of Redhill Biopharma Ltd-sp Adr. Learn more about fractional shares .

What are the returns that Redhill Biopharma Ltd-sp Adr has given to Indian investors in the last 5 years?

Redhill Biopharma Ltd-sp Adr stock has given -99.98% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?